PharmAbcine Inc. ntered into a strategic partnership with Samsung Biologics for the development and manufacturing of PMC-403 pipeline, the next generation therapeutic antibody candidate
The data Korea's Samsung Biologics Looks Strategically At PharmAbcine Deal appeared on ChinaSourcingNews.com.